Title: Recent Advances in Type 2 Diabetes Management

Abstract:
Type 2 diabetes mellitus (T2DM) is a metabolic disorder characterized by insulin resistance and chronic hyperglycemia. Recent therapies focus on SGLT2 inhibitors and GLP-1 receptor agonists, which offer improved glycemic control and cardiovascular benefits. This review explores the mechanism, efficacy, and safety of these new drug classes, and highlights the importance of early diagnosis and personalized treatment plans.
